MannKind Corp. (NSDQ:MNKD) and One Drop said today that the companies agreed to ink a collaborative deal to add MannKind’s Afrezza inhaled insulin to One Drop’s digital diabetes management platform. The group plans to evaluate access and cost saving initiatives, customized patient coaching and innovative packaging for a reusable Afrezza inhaler integrated with Bluetooth tech. […]
Big Data
How IBM is using deep learning to detect diabetic eye disease
IBM’s deep learning technology can detect and classify the severity of diabetic retinopathy with 86% accuracy, according to new research. The diagnostic tool could help doctors and physicians better understand disease progression and determine treatment, IBM said. The company’s technology was trained to identify lesions using more than 35,000 eye images. It can classify the […]
Patients twice as likely to take anticoagulants with artificial intelligence platform
Researchers from the Stern Stroke Center at Montefiore Medical Center published trial results this week showing that stroke survivors were twice as likely to take anticoagulants when using an artificial intelligence platform compared to patients receiving standard therapies. The AI platform, AiCure, features software algorithms on smartphones that confirm patient identify, medication and drug ingestion. […]
GCMI and BD to support medtech startups in Southeast U.S.
The Global Center for Medical Innovation has partnered with Becton, Dickinson and Co. (BD) to support the launch of the GCMI Medtech Accelerator. “Too many medtech startups fail unnecessarily due to a lack of bridge, or seed funding, required to advance far enough in the commercialization process to attract investment by a larger device company,” […]
Counterfeit prescription drug tracker raises $52m
TraceLink Inc. said yesterday that it raised $51.5 million in a Series C financing round, bringing its total raised to $77 million. The round was led by Goldman Sachs Growth Equity, joining FirstMark Capital, Volition Capital and F-Prime Capital. TraceLink developed a cloud-based global network of manufacturers, distributors, pharmacies and healthcare professionals. The firm’s system enables […]
Philips launches next-gen radiation dose management software
Royal Philips (NYSE:PHG) said today that it launched its 2nd generation DoseWise radiation dose management software platform for healthcare professionals to record and track radiation exposure in both patients and clinicians. The Dutch conglomerate said it’s 2nd generation version of DoseWise Portal has enhanced connectivity and informatics capabilities to help radiology departments address problems like […]
Broad Institute, IBM Watson launch initiative to study cancer drug resistance
IBM Watson Health (NYSE:IBM) and the Broad Institute said today that they’ve launched a research initiative with the hopes of discovering the basis for cancer drug resistance. The 5 year, $50 million collaboration will utilize the genetic information of thousands of drug resistant tumors and Watson’s machine learning methods to help understand the underlying mechanisms […]
Litmus Health looks to bring wearables to drug development
Litmus Health said yesterday that it launched its clinical data science platform into public beta. The company hopes to use big data from wearables and connected devices to help inform endpoints for Phase I & II clinical trials. The goal of its platform, according to Litmus, is to get pharmaceuticals to market faster by putting […]
Researchers look to create massive human cell ‘atlas’
Scientists launched a global initiative on Friday to map out and describe every cell in the human body in a vast atlas that could transform researchers’ understanding of human development and disease. The atlas, which could take more than a decade to complete, aims to chart the types and properties of all human cells across all […]